• Home
  • About
  • Press
  • Services
  • Legal
  • Payment
  • Contact
  • Facebook
  • Twitter
The Wall Street Analyzer

  • Featured Interviews
  • CEO Interviews
  • News Feed
  • Spotlight
  • Sectors
    • Biotech
    • Cannabis
    • Consumer
    • Energy
    • Healthcare
    • Market News
    • Technology
Latest News
  • [ August 20, 2025 ] Earth Science Tech, Inc. Board of Directors Approves Reduction of Authorized Common Stock News Feed
  • [ August 12, 2025 ] C-COM Receives $2 Million Antenna Orders News Feed
  • [ August 9, 2025 ] Earth Science Tech, Inc. Reports 61% Asset Growth to $7.69 Million and $8.7 Million in First Quarter Revenue Following Foundational Quarter of Strategic Acquisitions News Feed
  • [ August 7, 2025 ] Midnight Sun Initiates Drilling at Flagship Dumbwa Target News Feed
  • [ August 2, 2025 ] Biological Efficacy Demonstrated in a Phase 2 Clinical Trial of SGX945 for the treatment of Behçet’s Disease News Feed
  • [ July 17, 2025 ] Canadian Gold Corp. Field Exploration Underway at Hammond Reef South and Tartan West News Feed
  • [ July 9, 2025 ] Soligenix Corporate Update Letter – Key Highlights and Upcoming Milestones News Feed
HomeAuthorsThe Wall Street Analyzer

Articles by The Wall Street Analyzer

About The Wall Street Analyzer
The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.
No Picture
News Feed

Immune Pharmaceuticals Secures Funding of up to $21.5 Million from Institutional Investors

July 30, 2015 The Wall Street Analyzer Comments Off on Immune Pharmaceuticals Secures Funding of up to $21.5 Million from Institutional Investors

Up to $9.5 Million in Debt Financing and $12 Million in Equity Financing.

Company to Advance its Immuno-Dermatology and Inflammatory Bowel Disease Product Candidates
Lead Compound Bertilimumab, First-in-Class Autoimmune Therapy, a Priority
[…]

No Picture
News Feed

Educational Development Corporation Announces Results for First Quarter of Fiscal Year 2016

July 20, 2015 The Wall Street Analyzer Comments Off on Educational Development Corporation Announces Results for First Quarter of Fiscal Year 2016

NASDAQ:EDUC […]

No Picture
News Feed

Pacific Energy Development Announces Commencement of Drilling This Week on Seven New Wattenberg Wells

July 20, 2015 The Wall Street Analyzer Comments Off on Pacific Energy Development Announces Commencement of Drilling This Week on Seven New Wattenberg Wells

Will Also Participate in Additional Wattenberg Well […]

No Picture
News Feed

WSA Spotlights Three Canadian Companies in June That Are Making Big Moves

July 15, 2015 The Wall Street Analyzer Comments Off on WSA Spotlights Three Canadian Companies in June That Are Making Big Moves

Wall Street Analyzer’s CEO Interview Series […]

CEO Interviews

AirBoss of America Corp (TSX:BOS) (OTC:ABSSF) Management Interview

July 14, 2015 The Wall Street Analyzer Comments Off on AirBoss of America Corp (TSX:BOS) (OTC:ABSSF) Management Interview

Management Interview […]

No Picture
CEO Interviews

Chanticleer Holdings, Inc (NASDAQ:HOTR) CEO Interview

July 7, 2015 The Wall Street Analyzer Comments Off on Chanticleer Holdings, Inc (NASDAQ:HOTR) CEO Interview

Chanticleer Holdings, Inc (NASDAQ:HOTR) President and CEO: Michael Pruitt   THIS INTERVIEW HAS EXPIRED  

No Picture
News Feed

OCI Partners LP Announces Closing of New Incremental Term Loan

July 6, 2015 The Wall Street Analyzer Comments Off on OCI Partners LP Announces Closing of New Incremental Term Loan

(NYSE:OCIP) […]

No Picture
CEO Interviews

NioCorp Developments Ltd (TSXV:NB) (OTCQX:NIOBF) CEO: Mark Smith

June 23, 2015 The Wall Street Analyzer Comments Off on NioCorp Developments Ltd (TSXV:NB) (OTCQX:NIOBF) CEO: Mark Smith

Interview with CEO Mark Smith […]

No Picture
CEO Interviews

biOasis TECHNOLOGIES INC. (TSX VENTURE:BTI) (OTCQX:BIOAF) CEO Interview

June 22, 2015 The Wall Street Analyzer Comments Off on biOasis TECHNOLOGIES INC. (TSX VENTURE:BTI) (OTCQX:BIOAF) CEO Interview

Interview with CEO Rob Hutchison […]

CEO Interviews

PEDEVCO Corp. (NYSE MKT: PED) CEO Interview

June 18, 2015 The Wall Street Analyzer Comments Off on PEDEVCO Corp. (NYSE MKT: PED) CEO Interview

Interview with Frank Ingriselli, CEO […]

Posts navigation

« 1 … 137 138 139 … 159 »

News Wire

  • Earth Science Tech, Inc. Board of Directors Approves Reduction of Authorized Common Stock
    August 20, 2025 0
  • C-COM Receives $2 Million Antenna Orders
    August 12, 2025 0
  • Earth Science Tech, Inc. Reports 61% Asset Growth to $7.69 Million and $8.7 Million in First Quarter Revenue Following Foundational Quarter of Strategic Acquisitions
    August 9, 2025 0
  • Midnight Sun Initiates Drilling at Flagship Dumbwa Target
    August 7, 2025 0
  • Biological Efficacy Demonstrated in a Phase 2 Clinical Trial of SGX945 for the treatment of Behçet’s Disease
    August 2, 2025 0
  • Canadian Gold Corp. Field Exploration Underway at Hammond Reef South and Tartan West
    July 17, 2025 0

Featured

Featured Interviews

Earth Science Tech, Inc. (OTCID: ETST)

July 14, 2025 0

Interview with Giorgio Saumat, CEO and Chairman of the Board […]

Featured Interviews

Avalon Advanced Materials Inc. (TSX: AVL) (OTCQB: AVLNF)

April 24, 2025 0

Interview with Scott Montheith CEO and Andrew Ramcharan, VP of Corporate Development […]

Featured Interviews

Canadian Gold Corp. (TSXV: CGC) (OTC: STRRF)(8S8:FRA)

March 31, 2025 0

Interview with Michael Swistun, President & CEO […]

Featured Interviews

Soligenix (NASDAQ: SNGX) Interview with Christopher Schaber, PhD CEO and President

March 26, 2025 0

Interview with Christopher Schaber, PhD CEO and President […]




About Us

The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.
Quick links
  • Home
  • About
  • Press
  • Services
  • Legal
  • Payment
  • Contact
Stay connected
  • Facebook
  • Twitter
Recent Case Study
Biotech

Prodex, Inc (NASDAQ: PDEX)

June 20, 2023 Comments Off on Prodex, Inc (NASDAQ: PDEX)

Interview with Rick Van Kirk, CEO […]

Testimonials
Testimonials

Client Testimonials:

March 6, 2023 Comments Off on Client Testimonials:

“Our clients have been very pleased with the Wall Street Analyzer interviews. These have been in-depth pieces with thoughtful and educated questions which have afforded our clients a platform to fully articulate their company story […]

Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com